目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global proton pump inhibitors (PPIs) market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global proton pump inhibitors (ppis) market 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Route of Administration Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 OTC PPIs - Market size and forecast 2023-2028
Exhibit 34: Chart on OTC PPIs - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on OTC PPIs - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on OTC PPIs - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on OTC PPIs - Year-over-year growth 2023-2028 (%)
6.4 Prescription PPIs - Market size and forecast 2023-2028
Exhibit 38: Chart on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Prescription PPIs - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Prescription PPIs - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Route of Administration
7.1 Market segments
Exhibit 44: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibit 45: Data Table on Route of Administration - Market share 2023-2028 (%)
7.2 Comparison by Route of Administration
Exhibit 46: Chart on Comparison by Route of Administration
Exhibit 47: Data Table on Comparison by Route of Administration
7.3 Oral - Market size and forecast 2023-2028
Exhibit 48: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Oral - Year-over-year growth 2023-2028 (%)
7.4 Injectable - Market size and forecast 2023-2028
Exhibit 52: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Route of Administration
Exhibit 56: Market opportunity by Route of Administration ($ million)
Exhibit 57: Data Table on Market opportunity by Route of Administration ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Amgen Inc.
Exhibit 107: Amgen Inc. - Overview
Exhibit 108: Amgen Inc. - Product / Service
Exhibit 109: Amgen Inc. - Key offerings
12.4 AstraZeneca Plc
Exhibit 110: AstraZeneca Plc - Overview
Exhibit 111: AstraZeneca Plc - Product / Service
Exhibit 112: AstraZeneca Plc - Key news
Exhibit 113: AstraZeneca Plc - Key offerings
12.5 Aurobindo Pharma Ltd.
Exhibit 114: Aurobindo Pharma Ltd. - Overview
Exhibit 115: Aurobindo Pharma Ltd. - Product / Service
Exhibit 116: Aurobindo Pharma Ltd. - Key offerings
12.6 Bausch Health Companies Inc.
Exhibit 117: Bausch Health Companies Inc. - Overview
Exhibit 118: Bausch Health Companies Inc. - Business segments
Exhibit 119: Bausch Health Companies Inc. - Key news
Exhibit 120: Bausch Health Companies Inc. - Key offerings
Exhibit 121: Bausch Health Companies Inc. - Segment focus
12.7 Bayer AG
Exhibit 122: Bayer AG - Overview
Exhibit 123: Bayer AG - Business segments
Exhibit 124: Bayer AG - Key news
Exhibit 125: Bayer AG - Key offerings
Exhibit 126: Bayer AG - Segment focus
12.8 Dr Reddys Laboratories Ltd.
Exhibit 127: Dr Reddys Laboratories Ltd. - Overview
Exhibit 128: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 129: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 130: Dr Reddys Laboratories Ltd. - Segment focus
12.9 Eisai Co. Ltd.
Exhibit 131: Eisai Co. Ltd. - Overview
Exhibit 132: Eisai Co. Ltd. - Business segments
Exhibit 133: Eisai Co. Ltd. - Key offerings
Exhibit 134: Eisai Co. Ltd. - Segment focus
12.10 Eli Lilly and Co.
Exhibit 135: Eli Lilly and Co. - Overview
Exhibit 136: Eli Lilly and Co. - Product / Service
Exhibit 137: Eli Lilly and Co. - Key news
Exhibit 138: Eli Lilly and Co. - Key offerings
12.11 Glenmark Pharmaceuticals Ltd.
Exhibit 139: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 140: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 141: Glenmark Pharmaceuticals Ltd. - Key offerings
12.12 Pfizer Inc.
Exhibit 142: Pfizer Inc. - Overview
Exhibit 143: Pfizer Inc. - Product / Service
Exhibit 144: Pfizer Inc. - Key news
Exhibit 145: Pfizer Inc. - Key offerings
12.13 Sun Pharmaceutical Industries Ltd.
Exhibit 146: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 147: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 148: Sun Pharmaceutical Industries Ltd. - Key offerings
12.14 Takeda Pharmaceutical Co. Ltd.
Exhibit 149: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 150: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 151: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 152: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.15 Teva Pharmaceutical Industries Ltd.
Exhibit 153: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 154: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 155: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 156: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 157: Teva Pharmaceutical Industries Ltd. - Segment focus
12.16 The Procter and Gamble Co.
Exhibit 158: The Procter and Gamble Co. - Overview
Exhibit 159: The Procter and Gamble Co. - Business segments
Exhibit 160: The Procter and Gamble Co. - Key news
Exhibit 161: The Procter and Gamble Co. - Key offerings
Exhibit 162: The Procter and Gamble Co. - Segment focus
12.17 Zydus Lifesciences Ltd.
Exhibit 163: Zydus Lifesciences Ltd. - Overview
Exhibit 164: Zydus Lifesciences Ltd. - Business segments
Exhibit 165: Zydus Lifesciences Ltd. - Key offerings
Exhibit 166: Zydus Lifesciences Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 167: Inclusions checklist
Exhibit 168: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 169: Currency conversion rates for US$
13.4 Research methodology
Exhibit 170: Research methodology
Exhibit 171: Validation techniques employed for market sizing
Exhibit 172: Information sources
13.5 List of abbreviations
Exhibit 173: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global proton pump inhibitors (ppis) market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on OTC PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on OTC PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on OTC PPIs - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on OTC PPIs - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Prescription PPIs - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Prescription PPIs - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits45: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Route of Administration
Exhibits47: Data Table on Comparison by Route of Administration
Exhibits48: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Route of Administration ($ million)
Exhibits57: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Amgen Inc. - Overview
Exhibits108: Amgen Inc. - Product / Service
Exhibits109: Amgen Inc. - Key offerings
Exhibits110: AstraZeneca Plc - Overview
Exhibits111: AstraZeneca Plc - Product / Service
Exhibits112: AstraZeneca Plc - Key news
Exhibits113: AstraZeneca Plc - Key offerings
Exhibits114: Aurobindo Pharma Ltd. - Overview
Exhibits115: Aurobindo Pharma Ltd. - Product / Service
Exhibits116: Aurobindo Pharma Ltd. - Key offerings
Exhibits117: Bausch Health Companies Inc. - Overview
Exhibits118: Bausch Health Companies Inc. - Business segments
Exhibits119: Bausch Health Companies Inc. - Key news
Exhibits120: Bausch Health Companies Inc. - Key offerings
Exhibits121: Bausch Health Companies Inc. - Segment focus
Exhibits122: Bayer AG - Overview
Exhibits123: Bayer AG - Business segments
Exhibits124: Bayer AG - Key news
Exhibits125: Bayer AG - Key offerings
Exhibits126: Bayer AG - Segment focus
Exhibits127: Dr Reddys Laboratories Ltd. - Overview
Exhibits128: Dr Reddys Laboratories Ltd. - Business segments
Exhibits129: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits130: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits131: Eisai Co. Ltd. - Overview
Exhibits132: Eisai Co. Ltd. - Business segments
Exhibits133: Eisai Co. Ltd. - Key offerings
Exhibits134: Eisai Co. Ltd. - Segment focus
Exhibits135: Eli Lilly and Co. - Overview
Exhibits136: Eli Lilly and Co. - Product / Service
Exhibits137: Eli Lilly and Co. - Key news
Exhibits138: Eli Lilly and Co. - Key offerings
Exhibits139: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits140: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits141: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits142: Pfizer Inc. - Overview
Exhibits143: Pfizer Inc. - Product / Service
Exhibits144: Pfizer Inc. - Key news
Exhibits145: Pfizer Inc. - Key offerings
Exhibits146: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits147: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits148: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits149: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits150: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits151: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits152: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits153: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits154: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits155: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits156: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits157: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits158: The Procter and Gamble Co. - Overview
Exhibits159: The Procter and Gamble Co. - Business segments
Exhibits160: The Procter and Gamble Co. - Key news
Exhibits161: The Procter and Gamble Co. - Key offerings
Exhibits162: The Procter and Gamble Co. - Segment focus
Exhibits163: Zydus Lifesciences Ltd. - Overview
Exhibits164: Zydus Lifesciences Ltd. - Business segments
Exhibits165: Zydus Lifesciences Ltd. - Key offerings
Exhibits166: Zydus Lifesciences Ltd. - Segment focus
Exhibits167: Inclusions checklist
Exhibits168: Exclusions checklist
Exhibits169: Currency conversion rates for US$
Exhibits170: Research methodology
Exhibits171: Validation techniques employed for market sizing
Exhibits172: Information sources
Exhibits173: List of abbreviations